AptaBio Therapeutics Inc. (KOSDAQ: 293780)
South Korea
· Delayed Price · Currency is KRW
6,570.00
-170.00 (-2.52%)
Dec 19, 2024, 12:30 PM KST
AptaBio Therapeutics Revenue
AptaBio Therapeutics had revenue of 859.41M KRW in the quarter ending September 30, 2024, with 10,147.51% growth. This brings the company's revenue in the last twelve months to 2.91B, up 5,430.63% year-over-year. In the year 2023, AptaBio Therapeutics had annual revenue of 323.87M with 569.80% growth.
Revenue (ttm)
2.91B
Revenue Growth
+5,430.63%
P/S Ratio
47.67
Revenue / Employee
90.82M
Employees
32
Market Cap
165.59B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 323.87M | 275.52M | 569.80% |
Dec 31, 2022 | 48.35M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition